The antibody-based pharmaceuticals resource library’s Podcast

View Top 200 Chart

Back to Rankings Page

Education
**The antibody-based pharmaceuticals resource library’s Podcast**

Podcasts for antibody-based pharmaceuticals including Therapeutic antibody/Antibody-drug conjugates/vaccine/CAR-T/Immunotherapy. Creative-Biolabs, the provider, is an outsourced research organization for antibody-drug development.

Latest Episodes:

Ep.12 Adoptive NK Cell Therapies May 15, 2023

Show notes

This episode focuses on the approaches and current challenges in using natural killer cells as cancer immunotherapies.

Ep.11 Biology and Function of Natural Killer Cells May 15, 2023

Show notes

This episode focuses on the biology of natural killer (NK) cells and their function for application in tumor therapy.

Ep.10 Effects of Regulatory T Cells on Tumor Immunity and the Clinical Application Apr 06, 2023

Show notes

This episode focuses on the mechanisms of immunosuppression by regulatory T cells, including direct and indirect mechanisms.

Ep.9 Mechanism of Immunosuppression by Regulatory T Cells Apr 06, 2023

Show notes

This episode focuses on the regulatory T cell expansion as an attractive option to suppress the development of graft-versus-host disease.

Ep.8 Characterization And Functional Abilities of Regulatory T Cells Apr 06, 2023

Show notes

This episode focuses on the application of regulatory T cells for the prevention and treatment of graft-versus-host disease.

Vaccine for Cancer Immunotherapy Mar 05, 2023

Show notes

Cancer vaccines are designed to stimulate anti-tumor immunity through active immunization with tumor antigens and has long been envisioned as a key tool of effective cancer immunotherapy. Today we will go through the history, formulations, mechanisms of action, and clinical status of cancer vaccines. Creative Biolabs has been effectively supporting the cancer vaccine industry with our one-stop solutions for cancer vaccine discovery and development. We will accommodate the specific properties and clinical purpose of your vaccine candidate, and take careful scientific considerations to ensure the most appropriate solutions to develop your projects.

PROTAC Technology in Tumor Targeted Therapy Mar 01, 2023

Show notes

Today, we will explore the protac technology applied in tumor-targeted therapy. The following will be presented to you, such as a brief introduction to Protac, the mechanism of action, the advantages and disadvantages of protac as a drug, and the core content: the application of protac technology in tumor therapy. And the last part, the protac solutions provided by Creative Biolabs. If you have any questions about the PROCT development, please email us.

Macrophages as Targets in Cancer Immunotherapy Jan 30, 2023

Show notes

Due to the limitations and shortages of traditional cancer treatments, immunotherapy has become the most promising cancer treatment. Various cancer immunotherapy strategies have emerged. These include adoptive cellular immunotherapy, tumor vaccines, antibodies, immune checkpoint inhibitors, and small molecule inhibitors. Although most of these strategies are not meant to target macrophages directly or originally, macrophages contribute significantly to the final outcomes.

As a CRO company, Creative Biolabs offers first-in-class macrophage therapeutic development services. Please don’t hesitate to contact us if you are interested in our services or if you have any questions.

Does the Genosome Produce Toxicity in Vivo Jan 13, 2023

Show notes

Creative Biolabs has archived professional academic reports and the latest scientific progress of lipid-based drug delivery, by making it into a podcast column.

Pharmacokinetics of DNA-liposome Complexes Jan 13, 2023

Show notes

Creative Biolabs has archived professional academic reports and the latest scientific progress of lipid-based drug delivery, by making it into a podcast column.